Are immune checkpoint inhibitors (ICI) a valid option for papillary renal cell carcinoma (pRCC)? A multicenter retrospective study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreAre immune checkpoint inhibitors (ICI) a valid option for papillary renal cell carcinoma (pRCC)? A multicenter retrospective study.
Type de publicationJournal Article
Year of Publication2019
Auteursde Vries-Brilland M, Gross-Goupil M, Boughalem E, Beuselinck B, Thibault C, Chevreau C, Ladoire S, Barthelemy P, Negrier S, Borchiellini D, Huillard O, Geoffrois L, Gravis G, Saldana C, Thiery-Vuillemin A, Seegers V, Escudier B, Ravaud A, Albiges L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAR 1
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.7_suppl.582